Recent Finacing
Recent Raise
Cytometix is an early-stage biopharmaceutical company developing a beta-endorphin–inducing pain therapeutic and a subsequent asthma candidate, collaborating with the Medical College of Wisconsin toward IND advancement.
Focus Areas
Total Raised
Funding round